Get started
Author

Sinto Sebastian Chirackal

Lenalidomide Inhibits Thioredoxin Reductase (TrxR) in Multiple Myeloma (MM) Cells but Direct Inhibition of Trxr and Thioredoxin (Trx) Can Bypass Requirement of Cereblon (CRBN)
2016 · Sinto Sebastian Chirackal, Esteban Braggio, et al. · Blood · 2
Evaluation of Revised International Staging System for Transplant-Eligible Multiple Myeloma Patients
2016 · Veronica Gonzalez-Calle, Abigail Slack, et al. · Blood · 1
Role Of Folate Receptor Targeted Therapy In Multiple Myeloma
2013 · Sonali Panchabhai, Katalin Kelemen, et al. · Blood · 1
Mechanistic insights into the antiproliferative effect of the redox-active iron chelator Dp44mT on multiple myeloma cell lines
2025 · Aarti Sharma, Latha Pathangey, et al. · Hematology Transfusion and Cell Therapy
Ferritin H Knockout Induces Differential Immunomodulatory Drug Responses in Multiple Myeloma Cell Lines
2025 · Aarti Sharma, Latha Pathangey, et al. · European Journal Of Haematology
PDF
Unraveling Antioxidative Metabolic Pathways in Multiple Myeloma: Augmenting IMiD Sensitivity through Intracellular Cysteine Biosynthesis Inhibition
2023 · Sinto Sebastian Chirackal, Taro Hitosugi, et al. · Blood
PDF
Myeloma Cells Addicted to Glutamine for Biomass Production Are Sensitive to Lenalidomide
2019 · Sinto Chirackal, Esteban Braggio, et al. · Blood
Results of a Flow Cytometry Assay Measuring Oxidative Stress Relief As a Predictor of Immunomodulatory Drugs (IMIDs) Sensitivity in Myeloma
2018 · Luke Mountjoy, Sinto Chirackal, et al. · Blood
Ornithine Decarboxylase: Novel Prognostic Marker and Target for Multiple Myeloma Therapy
2015 · Sonali Panchabhai, Ilana Miriam Schlam, et al. · Blood
Immunomodulatory Drugs Inhibit H2O2 Decomposition in Multiple Myeloma Cells and Its Mediated Cytotoxicity Is Determined By Cellular Antioxidative Capacity
2015 · Sinto Sebastian Chirackal, Yuan Xiao Zhu, et al. · Blood
Works count: 10
Citation count: 4
H-index: 1
I10-index:
Year
Topic
Type